Posted on 08/11/2020 8:11:54 AM PDT by Hojczyk
Members of the National Institutes of Health's COVID-19 Treatment Guidelines Panel have financial ties to a company behind clinical trials of a drug to treat coronavirus, as well as to another large pharmaceutical company involved with developing a COVID-19 vaccine.
According to the NIH, members of the panel include U.S. physicians, statisticians, and other experts who are developing treatment guidelines on COVID-19 "intended for healthcare providers."
A total of eight panel members list a financial relationship with Gilead Sciences on the panel's Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics document: Judith Aberg, MD, Adaora Adimora, MD, Jason Baker, MD, Roger Bedimo, MD, Eric Daar, MD, David V. Glidden, PhD, Susanna Naggie, MD, and Pablo Tebas, MD
"The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery," Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), announced back on April 29 in an interview with NBC News,
Dr. William O'Neill, a cardiologist and Medical Director at the Henry Ford Health System in Detroit, Mich., told Just the News contributor Sharyl Attkisson in an interview for her news program "Full Measure" that he is less impressed with remdesivir.
"There is a lot of hype for the drug," said O'Neil, adding that he sees "no big benefit" to remdesivir after reading medical journal reports on it.
Andrew T. Pavia, MD and Rajesh Gandhi, MD list Merck on the NIH disclosure form.
Merck is currently conducting clinical trials for a COVID-19 vaccine. Merck's target date for a licensed COVID-19 vaccine is early 2021, according to recent congressional testimony.
(Excerpt) Read more at justthenews.com ...
The NIH, CDC and Big Pharma are an incestuous merry-go-round.
remdesivir you have to be in the hospital to use it....I think
3,000 vs 10 for the Hydroxychloroquine
Follow the money...
The NIH, CDC and Big Pharma are an incestuous merry-go-round.
Which makes them exactly the same as every other regulatory agency and the industry they're supposed to be regulating.
In politics, regulatory capture (also client politics) is a corruption of authority that occurs when a political entity, policymaker, or regulatory agency is co-opted to serve the commercial, ideological, or political interests of a minor constituency, such as a particular geographic area, industry, profession, or ideological group.When regulatory capture occurs, a special interest is prioritized over the general interests of the public, leading to a net loss for society. Government agencies suffering regulatory capture are called "captured agencies." The theory of client politics is related to that of rent-seeking and political failure; client politics "occurs when most or all of the benefits of a program go to some single, reasonably small interest (e.g., industry, profession, or locality) but most or all of the costs will be borne by a large number of people (for example, all taxpayers)."
The great mistake is thinking that this is somehow avoidable. It isn't.
It will always happen, when you give power to government.
When you let legislatures control what is bought and sold, the first thing up for sale are legislators.
Yes. Of course. It goes without saying. Medicine is irretrievably corrupt.
Same with Lyme Disease.
Vaccine still in development. So...
Antibiotic treatment got limited, there are many chronic sufferers, insurance declines further treatment, doctors get fined for doing more. So it’s “Oh, please, let there be a vaccine!”
“”Different groups suggest that the global market for a vaccine against Lyme disease is estimated at approximately $1 billion annually, based on current estimates of the cost of treating patients with acute and more chronic Lyme disease,” said Mark Wooten, PhD, professor of medical microbiology and immunology in the College of Medicine and Life Sciences at The University of Toledo.”
-https://www.healthline.com/health-news/lyme-disease-vaccine-update#A-new-option-to-stop-Lyme-disease
That’s interesting, I had not heard that term.
Exactly why cancer, diabetes, and a dozen other diseases will never be cured: too much R&D money and jobs involved.
“In the councils of government, we must guard against the acquisition of unwarranted influence, whether sought or unsought, by the military-industrial complex. The potential for the disastrous rise of misplaced power exists and will persist...we must also be alert to the equal and opposite danger that public policy could itself become the captive of a scientific-technological elite...As we peer into society’s future, we - you and I, and our government - must avoid the impulse to live only for today, plundering for our own ease and convenience the precious resources of tomorrow.”
Eisenhower farewell speech
(Beware the ) “domination of the nation’s scholars by Federal employment, project allocations, and the power of money.” Eisenhower
Read more at: http://www.nationalreview.com/article/420743/truth-safeguards-liberty
Well, this group certainly qualifies as “Scientific Technological Elite.”
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.